Clementia Pharmaceuticals Inc (CMTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Operating Expenses | 9,799 | 8,656 | 5,026 | 6,116 | 5,155 |
| Operating Income | -9,799 | -8,656 | -5,026 | -6,116 | -5,155 |
| Interest Expense | 29,416 | 14,678 | 36,347 | 42,317 | -3,477 |
| Other Income | 316 | 107 | 81 | 89 | 95 |
| Pre-tax Income | -38,899 | -23,227 | -41,292 | -48,344 | -1,584 |
| Income Tax | 106 | 98 | 44 | 30 | 44 |
| Net Income Continuous | -39,006 | -23,324 | -41,337 | -48,374 | -1,627 |
| Net Income | $-39,006 | $-23,324 | $-41,337 | $-48,374 | $-1,627 |
| EPS Basic Total Ops | -1.83 | -9.54 | -17.48 | -20.57 | -0.69 |
| EPS Basic Continuous Ops | -1.83 | -9.54 | -17.48 | -20.58 | -0.69 |
| EPS Diluted Total Ops | -1.83 | -9.54 | -17.48 | -20.57 | -0.69 |
| EPS Diluted Continuous Ops | -1.83 | -9.54 | -17.48 | -20.58 | -0.69 |
| EPS Diluted Before Non-Recurring Items | -1.83 | -9.54 | N/A | N/A | N/A |
| EBITDA(a) | $-9,745 | $-8,601 | $-4,985 | $-6,072 | $-5,112 |